Liquidia Urges SCOTUS to Restore Preclusive Effect to PTAB Final Written Decisions
Last week, biopharmaceutical company Liquidia Technologies filed a petition for writ of certiorari with the U.S. Supreme Court to appeal a Federal Circuit ruling that affirmed induced infringement findings against Liquidia following the patent at issue being invalidated by the PTAB.
Source: ipwatchdog.com